Work

A 13-years pharmacovigilance analysis of novel hormonal agents in prostate cancer using the FDA adverse event reporting system database

Year: 2024

Type: article

Study design: Observational Study

Source: Expert Opinion on Drug Safety

DOI: 10.1080/14740338.2024.2442514

Authors: Haiwei Xiao, Tao Qin, Yanping Wen, Liang Ai, Nabei Chen, Linhui Cao, Lisha Wu

Institutions: Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Guangzhou University of Chinese Medicine

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Beijing Xisike Clinical Oncology Research Foundation

Award: G1119431742

OpenAlex ID: W4405384770

FWCI: 3.053

Cites: 55

Cited by: 4

Related to: 10